The goal of the EBV in MS Platform is to better understand the role of EBV in the development of MS and in ongoing disease; and the potential to target EBV to prevent or treat MS
The goal of the EBV in MS Platform is to better understand the role of EBV in the development of MS and in ongoing disease; and the potential to target EBV to prevent or treat MS
“PLATYPUS” - PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis - multi-arm, multi-stage (MAMS) clinical trial which will test two repurposed drugs to help people living with progressive MS.
“PLATYPUS” - PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis - multi-arm, multi-stage (MAMS) clinical trial which will test two repurposed drugs to help people living with progressive MS.
Join us for news and views on the latest research, treatments, and advocacy efforts, as well as candid and informative interviews with our community; those living with MS and their families and carers, together with leading clinicians, researchers, and advocates.
Join us for news and views on the latest research, treatments, and advocacy efforts, as well as candid and informative interviews with our community; those living with MS and their families and carers, together with leading clinicians, researchers, and advocates.
The Neurological Alliance Australia (NAA) is calling for the establishment of a Taskforce for Neurological Conditions, to urgently address the needs of millions of forgotten Australians.
The Neurological Alliance Australia (NAA) is calling for the establishment of a Taskforce for Neurological Conditions, to urgently address the needs of millions of forgotten Australians.
Newcastle’s Professor Jeannette Lechner-Scott, an internationally recognised neurologist and leader in multiple sclerosis (MS) research and clinical care, has been…
